SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-148046
Filing Date
2022-05-12
Accepted
2022-05-12 07:07:03
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d361563d8k.htm   iXBRL 8-K 25194
2 EX-99.1 d361563dex991.htm EX-99.1 41019
6 GRAPHIC g361563g0512004245847.jpg GRAPHIC 3617
  Complete submission text file 0001193125-22-148046.txt   206519

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA caba-20220512.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20220512_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20220512_pre.xml EX-101.PRE 11718
8 EXTRACTED XBRL INSTANCE DOCUMENT d361563d8k_htm.xml XML 3468
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 22915665
SIC: 2836 Biological Products, (No Diagnostic Substances)